EPFL Innogrants: CHF 100,000 for Lab-Based Startups
If your startup emerged from EPFL research, Innogrants bridges the gap between lab and market. High time investment, but essential funding for that crucial transition period when you're too early for VCs but too advanced for pure research grants.
- Must originate from EPFL research
- Focus on commercializing scientific innovation
- Covers lab-to-market transition costs







